8-K - KPET Ultra Paceline Corp | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

KPET Ultra Paceline Corporation completed its initial public offering and concurrent private placement, raising over $200 million for a trust account to pursue a business combination within 24 months.

Key Takeaways

1The company completed its IPO of 20,000,000 units at $10.00 each, generating gross proceeds of $200 million.

2Simultaneously, it sold 235,000 private placement units to KPET Ultra Paceline Unit Holdings LLC for $2.35 million, subject to a 30-day lock-up.

3Three new independent directors were appointed to the board and audit committee, each purchasing 40,000 Class B shares.

4Approximately $200 million of net proceeds, including deferred underwriting fees, were deposited into a trust account, restricted until a business combination or liquidation.

5The company entered into multiple definitive agreements, including underwriting, warrant, and registration rights agreements, in connection with the offering.

Current Report Details

Event Type

Management Change+6 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement.** On March 30, 2026, the registration statement on Form S-1, as amended (File No. 333-294067) (the “ Registration St

Material Agreement

$10.00$11.50

Source Document

3.02

** **Unregistered Sales of Equity Securities.** On April 1, 2026, simultaneously with the closing of the IPO and pursuant to the Purchase Agreement, the Company

Securities Issuance

$10.00$2.4M

5.02

by reference. Other than the foregoing, none of the directors are party to any arrangement or understanding with any person pursuant to which they were appointe

Management Change

5.03

by reference. **Item 7.01** **Regulation FD Disclosure.** On March 30, 2026, the Company issued a press release, a copy of which is attached as Exhibit 99.1 to

Charter Amendment

7.01

and set forth in the attached press release included as Exhibit 99.1 to this report is deemed to be “furnished” solely pursuant to Item 7.01 of this report and

Regulation Fd

8.01

** **Other Events.** Of the net proceeds of the IPO and the sale of the Private Placement Units, $200,000,000, including $11,000,000 of deferred underwriting di

Other Event

$500.0K

9.01

** **Financial Statements and Exhibits.** (d) Exhibits. | Exhibit Number | | Description of Exhibits | |---|---|---| | 1.1 | | Underwriting Agreement, dated Mar

Exhibits Only

Source Document

Executive & Director Changes

Kneeland Youngblood

Director

Appointed

Effective: 2026-03-30

Not stated

Kathleen Philips

Director

Appointed

Effective: 2026-03-30

Not stated

James McKee

Director

Appointed

Effective: 2026-03-30

Not stated

Transaction Details

Material Agreement

Agreement: Underwriting Agreement
Parties: KPET Ultra Paceline Corporation and Deutsche Bank Securities Inc.

•Covers 20,000,000 units
•Includes an over-allotment option for up to 3,000,000 additional units

Exhibits (11)

10.1

LETTER AGREEMENT, DATED MARCH 30, 2026, AMONG THE COMPANY, ITS OFFICERS AND DIRECTORS, THE SPONSOR AND THE UNIT HOLDER SPONSOR

10.2

INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED MARCH 30, 2026, BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS TRUSTEE

10.3

REGISTRATION RIGHTS AGREEMENT, DATED MARCH 30, 2026, AMONG THE COMPANY, THE SPONSOR, THE UNIT HOLDER SPONSOR AND CERTAIN OTHER SECURITY HOLDERS NAMED THEREIN

10.4

ADMINISTRATIVE SUPPORT AGREEMENT, DATED MARCH 30, 2026, BETWEEN THE COMPANY AND UNIT HOLDER SPONSOR

10.5

PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, DATED MARCH 30, 2026, AMONG THE COMPANY, THE UNIT HOLDER SPONSOR AND THE OTHER PURCHASERS NAMED THEREIN

1.1

UNDERWRITING AGREEMENT, DATED MARCH 30, 2026, BETWEEN THE COMPANY AND DEUTSCHE BANK SECURITIES INC

3.1

AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

4.1

PRIVATE WARRANT AGREEMENT, DATED MARCH 30, 2026, BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT

4.2

PUBLIC WARRANT AGREEMENT, DATED MARCH 30, 2026, BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT

8-K

CURRENT REPORT

99.1

PRESS RELEASE, DATED MARCH 30, 2026